INMUNE BIO INC. (INMB) Operating margin 2020–2025
INMUNE BIO INC. (INMB) operating margin by fiscal year — reported operating income divided by reported revenue.
-94766.0%FY2025 · since FY2020: -111163.6% → -94766.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -94766.0% | +209769.7 pp |
| FY2024 | -304535.7% | -285348.0 pp |
| FY2023 | -19187.7% | -12249.0 pp |
| FY2022 | -6938.8% | +9167.9 pp |
| FY2021 | -16106.6% | +95057.0 pp |
| FY2020 | -111163.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice